mavacamten Archives - Hypertrophic Cardiomyopathy Association

Mavacamten Affects Diastolic Dysfunction

By Gordon Fox | November 9, 2022

Background HCM patients commonly suffer from diastolic dysfunction (also called heart failure with preserved ejection fraction (HFpEF), or left-sided heart failure): their hearts do not fill adequately. As a result, even after septal reduction therapy (SRT: myectomy or alcohol septal ablation), some patients are quite symptomatic. Can mavacamten (Camzyos) help relieve their symptoms? Now a…

Mavacamten instead of septal reduction?

By Gordon Fox | February 9, 2022

On April 2, Dr. Milind Y. Desai, a leading HCM researcher and practitioner, will present initial results on mavacamten’s use in severely obstructed HCM patients.